The View From Here – by Julian Davies

by Julian Davies
 

The Parvome

Zabriskie Point. Source

This is in response to Mark Martin’s prompt*; he is an in­teresting and eclectic character. Well, I was not inclined to write anything, but since this week has been spent on grant writing (for not very much money, this being the style in Canada) and today, being a sunny day, I decided to cut the grass but the handle kept on coming detached from the push mower which put me in a good mood for a rant (not a blog); I am also upset about the fact that Ro­ger Federer lost again and I don't like to see bad things happen to my heroes. But to come back to Mark's prompt, why do microbes make so many small molecules?
 

To start with I apologize for the fact that the question is biologically incorrect, since the only people who can answer "why" questions are priests. However, you know what I mean. I am very enthusiastic about the fact that the scientific world is becoming interested in biomes and their importance to eukaryotic life; it is about time! Jeff Gordon, Jeremy Nicholson, and others have confirmed the notion that bacteria are really good for us humans and we can begin to think se­riously about microbes as being truly important living beings. As you know, I have long been in­terested in how microbial small molecules fit into this picture.
 

As I pointed out in an earlier letter, there is a humungous microbial world of small molecules of great structural diversity (Mark Martin suggested "parvome," from the Latin, parvus, for "small," and I agree; I have always wanted my own "-ome.") Microbes are the most accomplished chemists on earth; interestingly, one of the greatest challenges for organic chemists is to design synthetic approaches to these molecules and many naturally-occurring compounds remain to be so made. But these small molecules were not produced to be PhD projects and neither were they made to cure our infectious diseases. The latter is one of the best examples of anthropocentric thinking, in my opinion. We use bacterial small molecules as drugs precisely because they exhibit dose re­sponse curves. At high doses they are good for us but at low doses they must possess activities that are good for microbes, more especially for microbial communities (the only way that mi­crobes exist in nature – well, maybe not in invasive infections).
 

So what do small molecules do? Our studies show that all natural products are bioactive, in the sense that at low (sub-inhibitory) concentrations they modulate bacterial transcription. Depending on the compound and its target, each small molecule influences a distinct spectrum of promoter responses. To me and some others, this implies that in the environment, bacterial communities are modulating their activities using a wide range of small molecule signals.
 

(Click to enlarge )
Antibiotic binding to bacterial ribosomes: many target sites for small molecule sig­naling. Source

I could say that this was a form of homeostasis, but it is premature to make this conclusion. I could also say that bacteria all have their own cell phones but this is a pri­mitive anthropomorphism! I think we must accept that this is a different form of cell-cell signaling than is nor­mally discussed, since the small molecule ligands interact with macromolecular receptors such as ribosomes, or the DNA replication, transcription, and cell wall complex­es. All this remains to be proven, of course, and some good imaging studies in soils and other environments would help.
 

On the other hand, some small molecules are so toxic that it is difficult to see how they could be anything other than real antibiotics. A good example is the enediyne class produced by a number of different bacteria and used as antitumor agents. Bacteria make them, use them (for what pur­pose?), and survive! The self-protection mechanisms must be extremely effective since one slip means death. Incidentally, I wonder if the natural bacterial protection mechanisms could be used to control the activities of these potent compounds during cancer chemotherapy? Someone must have thought of this.
 

Finally, there has been much discussion of late about the "environmental resistome." One can certainly find endogenous antibiotic resistance genes in most bacterial populations by cloning and testing in the lab. But is this their real function in nature? Could resistance be due to pleiotropic effects? Is much of the clinically significant resistance simply due to the over-expression of a he­terologous gene in a different cytoplasm?
 

So there you are. I hope that you have no concerns about my sanity; you can blame this post on Mark!

Yours in wonder (about microbes).

 

*Mark’s prompt: I would love to see a post from Julian Davies from UBC over his idea (presented at ASM) that there exists a microverse of small molecules in nature which have profound effects on microbes in the natural world.
 

Julian Davies is Professor emeritus at the University of British Co­lumbia and a Fellow of the Royal Society. He previously contri­but­ed a letter to this blog.

 
 

 
 

Comments

[R. G. E. Murray]

You can count on Julian to have something stimulating to say at the drop af a hat or a challenge. Yes, no doubt there are galaxies of small molecules in and around bacteria in communities and a lot of them must say and do something. However, there must also be a functional selection mechanism just as the overall genomic regulation has to make provision for functional sequencing and selection of required mechanisms and functions. It is clear that nature has the useful capability of seeing that genes or parts of genes that might be useful sometime are retained for future use while being either in repose or achieving some other function. I read today that the outermost cells on a sponge have functional genes that have a function in generating nerve cells in the metazoans. So one can argue for a form of conservation that all living things can mannage to their future advantage - to kill or to cure!